We’re moving on!
Join us at www.hcp.novartis.com—our new location for health care professionals to find product, access, and medical information. Now you can find the tools you need to help manage your patients, all in one place!
You’ll have access to the site in a moment, or click continue to close this message and advance directly to the site.
Clinical Development and Medical Affairs
Novartis is reimagining medicine through research and innovation.
Explore our resources for you and your patients.
Select an Area of Research
Meet Us
APHON | September 2-4, 2020
NORD | October 8-9, 2020
SCDAA | October 14-17, 2020
NACLC | October 16-17, 2020
Oncology Clinical Pathways Congress | October 16-18, 2020
AMCP NEXUS | October 20-23, 2020
SMR | October 2020
SITC | November 10-15, 2020
ASH | December 5-8, 2020
ASHP | December 6-10, 2020
SABCS | December 8-12, 2020
AML = acute myeloid leukemia; MDS = myelodysplastic syndromes; CML = chronic myeloid leukemia; PROS = PIK3CA-related overgrowth spectrum.
